Cancer Research UK scientists are investigating whether beta-blockers to disseminate the key to preventing breast cancer and continue to improve survival. Promising early results are presented on the eve of Awareness Month Breast Cancer in the Royal Society of Medicine.
Dr Des Powe, University of Nottingham Hospitals NHS Trust, in collaboration with scientists from Germany and Belfast recently funded by Cancer Research UK to see if women who are beta-blockers - drugs that are frequently used to treat "treatment of hypertension and anxiety - both before and during treatment for breast cancer lower risk of tumor recurrence, and if they survive longer.
Oncotarget previously published in the first study of beta-blockers and breast cancer last year in the journal, the researchers found that of 466 patients with breast cancer - the use of beta blockers before surgery for breast cancer less likely to be several years after treatment.
This study on the first results in the laboratory, a biological mechanism that may stop moving through beta-blockers and cancer have been largely built.
Metastases of breast cancer is the leading cause of death by disease - it is expected that about 30 percent of cases of breast cancer and liberation, but they constitute about 90 percent of all deaths from this disease. It is important to find new and effective ways to prevent cancer cells from spreading to other parts of the body.
Dr Des Powe, Cancer Research UK funded scientists from Nottingham University Hospitals NHS Trust, said. "Cancer can be considered as two distinct phases - before and after the spread of the disease many women are successfully treated for breast cancer, but in their first pair, the original tumor is a legacy - a branch of primary tumor cells, which means that the original tumor and allows your body to move in a process called metastasis ..
"It is absolutely crucial to the spread of cancer to overcome, if we really want the survival of breast cancer as a problem almost all deaths from the disease better. It's very exciting that we are funded by Cancer Research UK were to continue this work and that beta blockers improve survival in reality a large population of patients with breast cancer to see. This study will be large enough to determine if we have the clinical trials progress and determine what type of beta-blockers, the stronger the effect.
Dr Julie Sharp, senior information scientist at Cancer Research UK, said: "If beta-blockers are known drug can be a very interesting development that has the potential to save many lives, and we hope to have seen the results of the study in the coming years. "
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment